| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/18/2004 | EP1446155A1 Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides |
| 08/18/2004 | EP1446154A1 Pharmaceutical composition comprising factor vii polypeptides and alpha2 -antiplasmin polypeptides |
| 08/18/2004 | EP1446153A1 Pharmaceutical composition comprising factor vii polypeptides and tissue plasminogen inhibitors |
| 08/18/2004 | EP1446152A1 Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors |
| 08/18/2004 | EP1446151A1 Pharmaceutical composition comprising factor vii polypeptides and thrombomodulin polypeptides |
| 08/18/2004 | EP1446150A1 Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |
| 08/18/2004 | EP1446149A1 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides |
| 08/18/2004 | EP1446147A1 Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid |
| 08/18/2004 | EP1446146A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 08/18/2004 | EP1446145A1 Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides |
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP0744950B1 Agent for prophylaxis and treatment of thromboxane a2 mediated diseases |
| 08/18/2004 | CN1522299A Coagulation factor vii derivatives |
| 08/18/2004 | CN1522264A 抗cd40单克隆抗体 Monoclonal antibody anti-cd40 |
| 08/18/2004 | CN1522256A Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 08/18/2004 | CN1522248A Novel butadiene derivatives, process for preparation of the same and intermediates for the synthesis thereof |
| 08/18/2004 | CN1522160A Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
| 08/18/2004 | CN1522151A Modified fvii in treatment of ards |
| 08/18/2004 | CN1521192A Human erythropoietin Fc fusion protein with high bioactivity |
| 08/18/2004 | CN1520882A Trombolysis agent KGD - prourokinase chimaera, preparing process and application thereof |
| 08/18/2004 | CN1520880A Hemostatic |
| 08/18/2004 | CN1520853A Sonchifolia Hance solid medical preparation and its manufacture process |
| 08/18/2004 | CN1520852A Sonchifolia Hance oral liquid and its manufacture process |
| 08/18/2004 | CN1520837A Plant extract and compound for treating endotoxin blood disease, and its extraction method and application |
| 08/18/2004 | CN1520829A Earthworm freeze dried powder injection and preparation method |
| 08/18/2004 | CN1520809A Acidum transamicum sodium chloride injection liquid preparation method |
| 08/18/2004 | CN1162172C Traditional Chinese medicine for treating leukemia and concurrently treating aplastic anemia |
| 08/17/2004 | US6777434 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 08/17/2004 | US6777431 Non-convalent thrombin inhibitors |
| 08/17/2004 | US6777427 Tetrahydroquinoline compounds |
| 08/17/2004 | US6777413 For therapy and prophylaxis of conditions in mammals characterized by undesired thrombosis |
| 08/17/2004 | US6777409 For therapy of inflammation |
| 08/17/2004 | US6777390 Stable blood coagulation inhibitor-free factor vii preparation and method for preparing same |
| 08/17/2004 | US6776796 Antiinflammatory drug and delivery device |
| 08/17/2004 | CA2292921C Aryl carboxylic acid and tetrazole derivatives |
| 08/17/2004 | CA2212010C Extracts of shark cartilage, process of production and uses thereof |
| 08/17/2004 | CA2155673C N-alkyl-2-substituted atp analogues |
| 08/17/2004 | CA2122908C Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/12/2004 | WO2004068109A2 Autologous or homologous coagulant produced from anticoagulated whole blood |
| 08/12/2004 | WO2004067522A1 Azaphenylalanine derivatives and their use as antithrombotic agents |
| 08/12/2004 | WO2004067014A1 Solid preparation for dialysis and process for producing the same |
| 08/12/2004 | WO2004066977A1 Solid agent for dialysis and process for producing the same |
| 08/12/2004 | WO2004056384A3 Use of factor vii polypeptides for preventing formation of inhibitors to blood coagulation factor viii and ix |
| 08/12/2004 | WO2004052893A3 Substituted dihydropyrano indole-3,4-dione derivatives and 3-oxoacetic acid substituted 2-hydroxymethylindole derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | WO2003015606A3 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | US20040158048 Compounds that release nitric oxide at controlled rates upon photolysis |
| 08/12/2004 | US20040157924 Novel methods for using alkanoyloxymethyl esters |
| 08/12/2004 | US20040157914 Pyrrolidinone derivatives |
| 08/12/2004 | US20040157913 Irritable bowel syndrome ; gastrointestinal disorders |
| 08/12/2004 | US20040157868 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-beta 1 |
| 08/12/2004 | US20040157864 Compositions and methods for inducing osteogenesis |
| 08/12/2004 | US20040157861 Compositions and methods for inhibiting TGF-beta |
| 08/12/2004 | US20040157820 can stably transport oxygen; blood substitute for patients of a rare blood type, patients refusing blood transfusion for religious reasons and animal care |
| 08/12/2004 | US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 08/12/2004 | US20040157778 computer program, which can be used for obtaining optimized dosage regimens for a desired pharmacodynamic response |
| 08/12/2004 | US20040157773 Farnesyl protein transferase inhibitors for treating cachexia |
| 08/12/2004 | US20040157326 Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors |
| 08/12/2004 | US20040157300 Glycoprotein vi fusion proteins |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040157207 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander |
| 08/12/2004 | US20040156929 Rice cultivar C3GHi |
| 08/12/2004 | US20040156900 core of an active agent and a swelling agent, and a coating of film forming polymer, which swells when it imbibes fluid from the core and ruptures to release the drug in a pulse in a reliable manner |
| 08/12/2004 | US20040156899 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| 08/12/2004 | US20040156859 GP-41 peptides, BBB peptides, anticancer agents, antihistamines, bronchodilators, hypotensive agents, antiangina agents, opioids, analgesics, antidepressants, and hypothyroid agents reactive with amino, hydroxyl or thiol groups |
| 08/12/2004 | US20040156834 use in bone marrow transplantation, into bone marrow cavity or into extraskeletal sites, such as the kidney capsule, muscles, liver, abdominal wall; treatment of diseases affecting the stromal microenvironment that controls hematopoiesis |
| 08/12/2004 | CA2514001A1 Autologous or homologous coagulant produced from anticoagulated whole blood |
| 08/11/2004 | EP1445253A1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
| 08/11/2004 | EP1444986A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders |
| 08/11/2004 | EP1444981A1 Intracellular calcium concentration increase inhibitors |
| 08/11/2004 | EP1444234A2 Deuterated pyrazolopyrimidinones and drugs containing said compounds |
| 08/11/2004 | EP1444201A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 08/11/2004 | EP1444009A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors |
| 08/11/2004 | EP1443971A2 METHOD OF USING 18080, A HUMAN SERINE CARBOXYPEPTIDASE FAMILY MEMBER |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443953A2 Detection and treatment of intravascular lesions |
| 08/11/2004 | EP1443947A1 Use of defibrinated blood for the manufacture of a hemoglobin-based oxygen carrier |
| 08/11/2004 | EP1443944A1 Pharmaceutical applications of hyaluronic acid preparations |
| 08/11/2004 | EP1443937A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443925A1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1443907A1 Biocompatible polymer blends and uses thereof |
| 08/11/2004 | EP1315708B1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 08/11/2004 | EP1140918B1 Thrombin inhibitors |
| 08/11/2004 | EP1080075B1 Piperididinyl and n-amidinopiperidinyl derivatives |
| 08/11/2004 | EP0821728B1 Tie-2 ligands, methods of making and uses thereof |
| 08/11/2004 | EP0575464B1 Modified factor vii |
| 08/11/2004 | CN1520416A 碳水化合物衍生物 Carbohydrate derivatives |
| 08/11/2004 | CN1520403A Novel polymorph v of torasemide |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1519240A Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |
| 08/11/2004 | CN1519021A Stable erythropoietin of recombined human red blood cell |
| 08/11/2004 | CN1518999A Method for preparing pharmaceutics of a single drug of japanese ginseng and general saponin |
| 08/11/2004 | CN1518996A A series of Chinese traditional medicine for treating blood disease |
| 08/11/2004 | CN1518982A Active component of muskrat fragrant, preparing technique and usage |
| 08/11/2004 | CN1161468C MPL ligand analogs |